Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)49-61
Number of pages13
JournalAdvanced Drug Delivery Reviews
Volume52
Issue number1
DOIs
StatePublished - Oct 31 2001

Fingerprint

Retinal Diseases
Choroidal Neovascularization
Eye Diseases
Fluorescein Angiography
Regional Blood Flow
Macular Degeneration
Drug Delivery Systems
Liposomes
Lasers
Light
Temperature
Pharmaceutical Preparations
Therapeutics

Keywords

  • Age-related macular degeneration
  • Choroidal neovascularization
  • Drug delivery
  • Eye
  • Laser
  • Liposomes
  • Photodynamic

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

@article{ee49ab2463d240c7a211cde553ea53ab,
title = "Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye",
keywords = "Age-related macular degeneration, Choroidal neovascularization, Drug delivery, Eye, Laser, Liposomes, Photodynamic",
author = "Ran Zeimer and Goldberg, {Morton F}",
year = "2001",
month = "10",
day = "31",
doi = "10.1016/S0169-409X(01)00194-6",
language = "English (US)",
volume = "52",
pages = "49--61",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye

AU - Zeimer, Ran

AU - Goldberg, Morton F

PY - 2001/10/31

Y1 - 2001/10/31

KW - Age-related macular degeneration

KW - Choroidal neovascularization

KW - Drug delivery

KW - Eye

KW - Laser

KW - Liposomes

KW - Photodynamic

UR - http://www.scopus.com/inward/record.url?scp=0035980340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035980340&partnerID=8YFLogxK

U2 - 10.1016/S0169-409X(01)00194-6

DO - 10.1016/S0169-409X(01)00194-6

M3 - Article

C2 - 11672875

AN - SCOPUS:0035980340

VL - 52

SP - 49

EP - 61

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 1

ER -